This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Genentech, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Shan Chung: Innovator in Transcytosis Assays
Introduction
Shan Chung is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of methods for measuring transcytosis. His work is crucial for advancing therapeutic antibody molecules and Fc-fusion proteins.
Latest Patents
Shan Chung holds a patent for an "In vitro transcytosis assay." This patent relates to methods and compositions that are useful for measuring the transcytosis of a molecule. Specifically, it focuses on in vitro receptor-dependent transcytosis assays that evaluate the clearance rates of therapeutic antibody molecules and Fc-fusion proteins in humans and animals. He has 1 patent to his name.
Career Highlights
Shan Chung is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His role at Genentech allows him to work on cutting-edge research that has the potential to impact patient care significantly.
Collaborations
Throughout his career, Shan has collaborated with talented individuals such as Van Hong Nguyen and An Song. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Shan Chung's contributions to the field of biotechnology, particularly through his patent on transcytosis assays, highlight his role as an influential inventor. His work at Genentech continues to pave the way for advancements in therapeutic treatments.